Stuart Therapeutics
Manufacturing · Florida, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
411 SE Osceola St Ste 203, Stuart, Flori...Phone Number
(772) 678-7307Website
www.stuarttherapeutics.comRevenue
<$5 MillionIndustry
About Stuart Therapeutics
Stuart Therapeutics is a clinical stage pharmaceutical company dedicated to developing innovative treatments for chronic eye diseases, including Dry Eye Disease, Glaucoma, and Retinal Disease. Their proprietary technology, PolyCol(), focuses on repairing disease-damaged helical collagen in the extracellular matrix, addressing previously undruggable targets in the human body. Founded in 2018, the company aims to preserve visual function and improve the quality of life for patients affected by these conditions. Stuart Therapeutics serves a diverse clientele, including patients suffering from chronic eye diseases and healthcare professionals seeking advanced therapeutic solutions.Explore more
Stuart Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Stuart Therapeutics
Compare insights from companies similar to Stuart Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Stuart Therapeutics Tech Stack
A closer look at the technologies used by Stuart Therapeutics
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Stuart Therapeutics
Sign Up For FreeTo access detailed company insights
Stuart Therapeutics is a clinical stage pharmaceutical company dedicated to developing innovative treatments for chronic eye diseases, including Dry Eye Disease, Glaucoma, and Retinal Disease. Their proprietary technology, PolyCol(), focuses on repairing disease-damaged helical collagen in the extracellular matrix, addressing previously undruggable... Read More
